Safety and Immunogenicity Among Adults of Fluzone Quadrivalent, Fluzone Intradermal, and Fluzone High-Dose Influenza Virus Vaccines, 2013-2014 Formulations

Trial Profile

Safety and Immunogenicity Among Adults of Fluzone Quadrivalent, Fluzone Intradermal, and Fluzone High-Dose Influenza Virus Vaccines, 2013-2014 Formulations

Completed
Phase of Trial: Phase IV

Latest Information Update: 07 Oct 2014

At a glance

  • Drugs Influenza virus vaccine (Primary) ; Influenza virus vaccine (Primary)
  • Indications Influenza virus infections
  • Focus Adverse reactions
  • Sponsors sanofi pasteur
  • Most Recent Events

    • 17 Sep 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
    • 25 Sep 2013 Planned End Date changed from 1 Oct 2013 to 1 Aug 2014 as reported by ClinicalTrials.gov.
    • 25 Sep 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top